1537P Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

20209 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of Oncology

Volume 31, pp. S944-S944

Field-Weighted Citation Impact: 0.59